# Effects of Somatostatin on Liver in ADPKD

> **NCT02119052** · PHASE2,PHASE3 · COMPLETED · sponsor: **Federico II University** · enrollment: 35 (actual)

## Conditions studied

- Autosomal Dominant Polycystic Kidney Disease

## Interventions

- **DRUG:** octeotride
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02119052
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2013-09
- **Final completion:** —
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02119052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02119052, "Effects of Somatostatin on Liver in ADPKD". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02119052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*